Atrial Fibrillation is defined as the type of cardiac arrhythmia distinguished by an abnormal heart rhythm due to disturbance in heart’s electrical system. This is considered as the most prevalent types of cardiac arrhythmia. Atrial fibrillation also referred as A-fib or AF. Increase in prevalence of AF with rise in product approvals over this forecast period is expected to drive the market growth.
Increase in prevalence of atrial fibrillation is key driving factor which is expected to boost the global atrial fibrillation market growth. For instance, as per the study “Prevalence of atrial fibrillation in various socioeconomic regions of China and its association with stroke’’ will positively influence the market growth. Furthermore, rise in geriatric population is also propel the market growth during this forecast timeline. For instance, as per the WHO, geriatric population is projected to reach 2 billion by 2050 from 900 million in 2015. Also, increase in technological advancements will fuel the market growth during this forecast period. In addition to that, rise in adoption of closure devices for the treatment of atrial fibrillation is expected to support the global atrial fibrillation market growth. The increase in research and development activities expected to offer lucrative growth opportunities to market in near future.
High cost of atrial fibrillation treatment incurred by the patient is major restraint which is expected to limit the global atrial fibrillation market growth. Further, product recall and stringent product approval regulations will hinder the market growth. For instance, in 2019, Medtronic received Food and Drug Administration recall for implemented cardiac pacemakers from market. In addition to that, lack of skilled professionals will hamper the market growth.
Global Atrial Fibrillation Market is segmented on the basis of procedure such as Pharmacological (Anti-arrhythmic and Anti-coagulant), and Non-pharmacological (Catheter Ablation Procedures, Maze Surgery, and Electric Cardio version).
Further, Global Atrial Fibrillation Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are profiled in this report such as Abbott Laboratories, AtriCure Inc, Siemens AG, Koninklijke Philips N.V., Biotronik SE & Co. KG, Medtronic plc, St. Jude Medical, Inc, Boston Scientific Corporation, MicroPort Scientific Corporation, and Johnson & Johnson.
o Anti-arrhythmic
o Anti-coagulant
o Catheter Ablation Procedures
o Maze Surgery
o Electric Cardio version
Market Drivers
Increase in prevalence of atrial fibrillation is key driving factor which is expected to boost the global atrial fibrillation market growth. For instance, as per the study “Prevalence of atrial fibrillation in various socioeconomic regions of China and its association with stroke’’ will positively influence the market growth. Furthermore, rise in geriatric population is also propel the market growth during this forecast timeline. For instance, as per the WHO, geriatric population is projected to reach 2 billion by 2050 from 900 million in 2015. Also, increase in technological advancements will fuel the market growth during this forecast period. In addition to that, rise in adoption of closure devices for the treatment of atrial fibrillation is expected to support the global atrial fibrillation market growth. The increase in research and development activities expected to offer lucrative growth opportunities to market in near future.
Market Restraints
High cost of atrial fibrillation treatment incurred by the patient is major restraint which is expected to limit the global atrial fibrillation market growth. Further, product recall and stringent product approval regulations will hinder the market growth. For instance, in 2019, Medtronic received Food and Drug Administration recall for implemented cardiac pacemakers from market. In addition to that, lack of skilled professionals will hamper the market growth.
Market Segmentation
Global Atrial Fibrillation Market is segmented on the basis of procedure such as Pharmacological (Anti-arrhythmic and Anti-coagulant), and Non-pharmacological (Catheter Ablation Procedures, Maze Surgery, and Electric Cardio version).
Further, Global Atrial Fibrillation Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are profiled in this report such as Abbott Laboratories, AtriCure Inc, Siemens AG, Koninklijke Philips N.V., Biotronik SE & Co. KG, Medtronic plc, St. Jude Medical, Inc, Boston Scientific Corporation, MicroPort Scientific Corporation, and Johnson & Johnson.
Market Taxonomy
By Procedure
- Pharmacological
o Anti-arrhythmic
o Anti-coagulant
- Non-pharmacological
o Catheter Ablation Procedures
o Maze Surgery
o Electric Cardio version
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Atrial Fibrillation Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
Table of Contents
1 Introduction
2 Research Methodology
4 Global Atrial Fibrillation Market Outlook
5 Global Atrial Fibrillation Market, By Procedure
6 Global Atrial Fibrillation Market, By Region
7 North America Atrial Fibrillation Market Analysis and Forecast (2020 - 2027)
8 Europe Atrial Fibrillation Market Analysis and Forecast (2020 - 2027)
9 Asia Pacific Atrial Fibrillation Market Analysis and Forecast (2020 - 2027)
10 Latin America Atrial Fibrillation Market Analysis and Forecast (2020 - 2027)
11 Middle East Atrial Fibrillation Market Analysis and Forecast (2020 - 2027)
12 Competitive Analysis
13 Company Profiles
Companies Mentioned
- Abbott Laboratories
- AtriCure Inc
- Siemens AG
- Koninklijke Philips N.V.
- Biotronik SE & Co. KG
- Medtronic plc
- St. Jude Medical Inc
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- Johnson & Johnson.
